Telavancin (Vibativ): a new glycopeptide antibiotic

Telavancin better than vancomycin?

Correspondence to Mark Nolan, EJHP correspondent; [email protected]

Competing interests None.

Provenance and peer review Commissioned; internally peer reviewed.

European Journal of Hospital Pharmacy 19(5):p 464, October 2012. | DOI: 10.1136/ejhpharm-2012-000108